Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare cidofovir with a commonly used treatment regimen, ganciclovir given by mouth
(oral) and through an eye device (intraocular) , in order to determine the safety and
effectiveness of cidofovir in preventing vision loss in patients who have AIDS complicated by
CMV (cytomegalovirus) retinitis.
Cidofovir needs to be compared to ganciclovir to determine the best way to treat CMV
retinitis.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)